比罗陀社区卫生中心提前取出依托孕诺酮皮下埋植避孕剂。
Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
机构信息
Department of Family Medicine and Primary Health Care, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, Pretoria.
出版信息
S Afr Fam Pract (2004). 2022 Jul 7;64(1):e1-e6. doi: 10.4102/safp.v64i1.5407.
BACKGROUND
The etonogestrel subcutaneous contraceptive implant offers efficacy for three years, but some women remove it earlier than prescribed. This study discusses factors associated with the early removal of these implants at a Pretoria community health centre between 01 January 2020 to 30 June 2020.
METHODS
A cross-sectional study using a piloted and researcher assistant-administered questionnaire.
RESULTS
Of the 124 participants who removed their etonogestrel subcutaneous contraceptive implant earlier than prescribed, most were single, unemployed, in the age group 30-39 years, Christian, with secondary level education and with parity one or more. Etonogestrel subcutaneous contraceptive implant pre-insertion counselling was given to all participants, most of whom had not previously used contraceptives. Those participants with previous contraceptive use had used injectables. Long-term contraception was the main reason for getting the etonogestrel subcutaneous contraceptive implant. Most participants did not attend post-insertion counselling. Heavy bleeding was the most common side effect and reason for early removal. Fifty-one participants kept the etonogestrel subcutaneous contraceptive implant in for a longer period of 12-23 months. From participants' responses, it seems that Etonogestrel implants may be offered from as early as 15-20 years of age.
CONCLUSION
Women having etonogestrel subcutaneous contraceptive implants removed early at a Pretoria community health centre tended to be young, single, unemployed, Christian, with a secondary level education and with parity one or more. All participants attended the etonogestrel subcutaneous contraceptive implant pre-insertion counselling services but not the post-counselling services. Heavy bleeding was the main reason for the early removal of the etonogestrel subcutaneous contraceptive implant.
背景
依托孕诺酮皮下埋植避孕剂的功效可持续三年，但有些女性会提前将其取出。本研究讨论了 2020 年 1 月 1 日至 6 月 30 日期间，比勒陀利亚社区卫生中心提前取出这些埋植剂的相关因素。
方法
采用问卷调查的方法，进行了一项横断面研究，问卷经过预试验和研究助理的测试。
结果
在 124 名提前取出依托孕诺酮皮下埋植避孕剂的参与者中，大多数为单身、失业，年龄在 30-39 岁，基督教徒，接受过中等教育，生育一个或多个孩子。所有参与者在植入前都接受了依托孕诺酮皮下埋植避孕剂咨询，但大多数人以前没有使用过避孕药具。那些以前使用过避孕药具的参与者曾使用过注射剂。长期避孕是植入依托孕诺酮皮下埋植避孕剂的主要原因。大多数参与者没有参加植入后的咨询。大出血是最常见的副作用和提前取出的主要原因。51 名参与者将依托孕诺酮皮下埋植避孕剂保留了 12-23 个月。根据参与者的回答，似乎可以从 15-20 岁开始提供依托孕诺酮植入物。
结论
比勒陀利亚社区卫生中心提前取出依托孕诺酮皮下埋植避孕剂的女性倾向于年轻、单身、失业、基督教徒、中等教育程度和生育一个或多个孩子。所有参与者都参加了依托孕诺酮皮下埋植避孕剂的植入前咨询服务，但没有参加植入后的咨询服务。大出血是提前取出依托孕诺酮皮下埋植避孕剂的主要原因。
Zotero 插件